【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 7
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Dyskinesia Overview 10
Therapeutics Development 11
Pipeline Products for Dyskinesia – Overview 11
Pipeline Products for Dyskinesia – Comparative Analysis 12
Dyskinesia – Therapeutics under Development by Companies 13
Dyskinesia – Therapeutics under Investigation by Universities/Institutes 16
Dyskinesia – Pipeline Products Glance 17
Late Stage Products 17
Clinical Stage Products 18
Early Stage Products 19
Dyskinesia – Products under Development by Companies 20
Dyskinesia – Products under Investigation by Universities/Institutes 23
Dyskinesia – Companies Involved in Therapeutics Development 24
Adamas Pharmaceuticals, Inc. 24
Addex Therapeutics Ltd 25
Advicenne Pharma 26
Amarantus Bioscience Holdings, Inc. 27
Astraea Therapeutics, LLC 28
Auspex Pharmaceuticals, Inc. 29
BioMarin Pharmaceutical Inc. 30
Catalyst Pharmaceutical Partners, Inc. 31
Contera Pharma ApS 32
EpiVax, Inc. 33
Heptares Therapeutics Ltd. 34
Integrative Research Laboratories Sweden AB 35
Ipsen S.A. 36
Medicure Inc. 37
Medy-Tox Inc. 38
Merz Pharmaceuticals GmbH 39
Neurim Pharmaceuticals Ltd 40
Neurocrine Biosciences, Inc. 41
Neurolixis Inc. 42
Novartis AG 43
Osmotica Pharmaceutical Corp. 44
Otsuka Holdings Co., Ltd. 45
Santhera Pharmaceuticals Holding AG 46
SciFluor Life Sciences, LLC 47
Synchroneuron Inc. 48
Targacept, Inc. 49
Upsher-Smith Laboratories, Inc. 50
Dyskinesia – Therapeutics Assessment 51
Assessment by Monotherapy Products 51
Assessment by Combination Products 52
Assessment by Target 53
Assessment by Mechanism of Action 55
Assessment by Route of Administration 57
Assessment by Molecule Type 59
Drug Profiles 61
(dextromethorphan hydrobromide + quinidine sulfate) – Drug Profile 61
Product Description 61
Mechanism of Action 61
R&D Progress 61
abobotulinumtoxin A – Drug Profile 63
Product Description 63
Mechanism of Action 63
R&D Progress 63
abobotulinumtoxin A next generation – Drug Profile 65
Product Description 65
Mechanism of Action 65
R&D Progress 65
acamprosate calcium SR – Drug Profile 66
Product Description 66
Mechanism of Action 66
R&D Progress 66
ADV-6979 – Drug Profile 68
Product Description 68
Mechanism of Action 68
R&D Progress 68
amantadine hydrochloride ER – Drug Profile 69
Product Description 69
Mechanism of Action 69
R&D Progress 69
amantadine hydrochloride ER – Drug Profile 71
Product Description 71
Mechanism of Action 71
R&D Progress 71
AQW-051 – Drug Profile 72
Product Description 72
Mechanism of Action 72
R&D Progress 72
AT-127 – Drug Profile 73
Product Description 73
Mechanism of Action 73
R&D Progress 73
AT-326 – Drug Profile 74
Product Description 74
Mechanism of Action 74
R&D Progress 74
AT-403 – Drug Profile 75
Product Description 75
Mechanism of Action 75
R&D Progress 75
AVP-786 – Drug Profile 76
Product Description 76
Mechanism of Action 76
R&D Progress 76
befiradol – Drug Profile 78
Product Description 78
Mechanism of Action 78
R&D Progress 78
CPP-115 – Drug Profile 79
Product Description 79
Mechanism of Action 79
R&D Progress 79
dipraglurant ER – Drug Profile 81
Product Description 81
Mechanism of Action 81
R&D Progress 81
dipraglurant IR – Drug Profile 82
Product Description 82
Mechanism of Action 82
R&D Progress 82
Drugs for Dyskinesia – Drug Profile 83
Product Description 83
Mechanism of Action 83
R&D Progress 83
Drugs for Tardive Dyskinesia – Drug Profile 84
Product Description 84
Mechanism of Action 84
R&D Progress 84
dutetrabenazine ER – Drug Profile 85
Product Description 85
Mechanism of Action 85
R&D Progress 85
eltoprazine – Drug Profile 86
Product Description 86
Mechanism of Action 86
R&D Progress 86
fipamezole – Drug Profile 88
Product Description 88
Mechanism of Action 88
R&D Progress 88
HTL-14242 – Drug Profile 90
Product Description 90
Mechanism of Action 90
R&D Progress 90
IRL-790 – Drug Profile 91
Product Description 91
Mechanism of Action 91
R&D Progress 91
JM-010 – Drug Profile 92
Product Description 92
Mechanism of Action 92
R&D Progress 92
MRZ-8676 – Drug Profile 93
Product Description 93
Mechanism of Action 93
R&D Progress 93
naluzotan – Drug Profile 94
Product Description 94
Mechanism of Action 94
R&D Progress 94
Neu-120 – Drug Profile 95
Product Description 95
Mechanism of Action 95
R&D Progress 95
Neu-240 – Drug Profile 96
Product Description 96
Mechanism of Action 96
R&D Progress 96
onabotulinumtoxin A – Drug Profile 97
Product Description 97
Mechanism of Action 97
R&D Progress 97
onabotulinumtoxin A – Drug Profile 98
Product Description 98
Mechanism of Action 98
R&D Progress 98
PEUN-3 – Drug Profile 99
Product Description 99
Mechanism of Action 99
R&D Progress 99
RG-2833 – Drug Profile 100
Product Description 100
Mechanism of Action 100
R&D Progress 100
Small Molecule for Dyskinesia – Drug Profile 102
Product Description 102
Mechanism of Action 102
R&D Progress 102
Small Molecule for Dyskinesia and Hyperkinesia – Drug Profile 103
Product Description 103
Mechanism of Action 103
R&D Progress 103
Small Molecules to Antagonize Metabotropic Glutamate Receptor 5 (mGluR5) for Dyskinesia – Drug Profile 104
Product Description 104
Mechanism of Action 104
R&D Progress 104
Tardoxal – Drug Profile 105
Product Description 105
Mechanism of Action 105
R&D Progress 105
TC-8831 – Drug Profile 106
Product Description 106
Mechanism of Action 106
R&D Progress 106
valbenazine – Drug Profile 107
Product Description 107
Mechanism of Action 107
R&D Progress 107
Dyskinesia – Recent Pipeline Updates 109
Dyskinesia – Dormant Projects 136
Dyskinesia – Discontinued Products 138
Dyskinesia – Product Development Milestones 139
Featured News & Press Releases 139
Feb 10, 2015: Amarantus Announces Publication in BRAIN of Eltoprazine Phase 2a Clinical Study for Treating Parkinson’s Disease Levodopa-Induced Dyskinesia 139
Feb 09, 2015: Adamas Pharmaceuticals’ Phase 2/3 Clinical Study Published in Movement Disorders 140
Feb 03, 2015: Auspex Pharmaceuticals Completes Enrollment in a Pivotal Clinical Trial of SD-809 in Tardive Dyskinesia 141
Jan 19, 2015: Addex and Dystonia Medical Research Foundation Announce Partnership to Explore the Therapeutic use of Dipraglurant in the Treatment of Dystonia 142
Jan 12, 2015: Auspex Announces Favorable Topline Results From Thorough QT Clinical Trial of SD-809 143
Jan 08, 2015: Amarantus to Participate in the Eighth Annual OneMedForum Conference on January 12 – 13, 2015 144
Oct 30, 2014: Auspex Pharmaceuticals Initiates Second Pivotal Clinical Trial for SD-809 in Tardive Dyskinesia 144
Oct 30, 2014: Neurocrine Biosciences Receives Breakthrough Therapy Designation for NBI-98854 in Tardive Dyskinesia 145
Oct 28, 2014: Adamas Pharmaceuticals Expands Its Phase 3 Program With ADS-5102 for the Treatment of Levodopa-induced Dyskinesia in Patients With Parkinson’s Disease 146
Oct 20, 2014: Neurocrine Announces Initiation Of Phase III Study For VMAT2 Inhibitor NBI-98854 147
Appendix 148
Methodology 148
Coverage 148
Secondary Research 148
Primary Research 148
Expert Panel Validation 148
Contact Us 148
Disclaimer 149
【レポート販売概要】
■ タイトル：ジスキネジア(Dyskinesia)：治療薬開発パイプライン動向（2015年上半期版）■ 英文：Dyskinesia - Pipeline Review, H1 2015
■ 発行日：2015年3月11日
■ 調査会社：Global Markets Direct
■ 商品コード：GMDHC6258IDB
■ 調査対象地域：グローバル
- 腎性貧血(Renal Anemia)：世界の治験レビュー2014年下半期版Renal Anemia Global Clinical Trials Review, H2, 2014 Summary GlobalData's clinical trial report, “Renal Anemia Global Clinical Trials Review, H2, 2014" provides data on the Renal Anemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Renal Anemia. It includes an overview of the trial numbers and their recruitment status as per the sit …
- ナノ粒子分析の世界市場：粒度、ゼータ電位、分子量、フロー特性、粒子濃度、分子構造分析On the basis of technology, the nanoparticle analysis market is divided into seven segments, namely, dynamic light scattering (DLS) measurement, microscopy, nanoparticle tracking analysis (NTA), laser diffraction, X-ray diffraction (XRD), resonant mass measurement, and other technologies. Other technologies segment comprises of nanoparticle surface area monitor (NSAM), differential mobility analyz …
- トキソプラズマ病検査の世界市場2015The report presents a detailed analysis of the Toxoplasmosis diagnostics market in the US, Europe, (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Toxoplasmosis definition, epidemiology and etiology are reviewed. The report provides the 5- and 10-year test volume and sales forecasts by country for the following market segments: - Hospitals &n …
- 世界の低公害車（低排出ガス車）市場動向（2012-2016）TechNavio's analysts forecast the Global Low Emission Vehicle market to grow at a CAGR of 30.65 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increase in initiatives from governments across the world promoting low emission vehicles. The Global Low Emission Vehicle market has also been witnessing a reduction in the price of vehicle batteries in …
- 産業用ファブリックの世界市場予測（～2023年）：ポリアミド、ポリエステル、アラミド、複合材料The market size of industrial fabric is estimated at USD 120.94 billion in 2018 and is projected to reach USD 153.60 billion by 2023, at a CAGR of 4.9% between 2018 and 2023. The growth of the market can be attributed to the increasing use of industrial fabrics in the automotive industry owing to the superior properties offered by these fabrics, such as high strength, rigidity, and heat resistance …
- 世界のウェーハ洗浄装置市場：装置種類別（枚葉式スプレーシステム、バッチ式スプレー洗浄システム、スクラバー）、用途別、技術別、動作モード別、ウェーハサイズ別、地域別“The wafer cleaning equipment market projected to grow at a CAGR of 10.3% during 2020–2025.” The wafer cleaning equipment market size is expected to grow from USD 7.4 billion in 2020 to USD 12.1 billion by 2025; it is projected to grow at a CAGR of 10.3% during the forecast period. Rise in the conventional application of MEMS and expansion in the number of cleaning steps in the wafer manufacturing …
- カーボンナノチューブ（CNT）の世界市場2016-2020About Carbon Nanotube CNT is a tube-shaped material made of carbon, with diameters in the range of less than 1 nanometer to 50 nanometers. It is in the form of a graphite layer that has continuous unbroken hexagonal mesh with carbon molecules at the edges of hexagons. Technavio’s analysts forecast the global carbon nanotube market to grow at a CAGR of 10.16% during the period 2016-2020. [Covered i …
- 非GMO食品の世界市場2017-2021About Non-GMO Foods The global non-GMO foods market is growing at a steady pace. The increase in the number of health-conscious people and increasing demand for non-GMO food products by middle class families are the primary reasons for the growth of the market. The rising demand for organic food products has also increased the demand for non-GMO food products from consumers. However, premium prici …
- 骨疾患/ミネラル疾患診断検査の世界市場2015-2019About bone and mineral diagnostic testing Bone and mineral disorders are caused by deficiency of minerals such as calcium, phosphorus, vitamin D, and abnormalities of bone structure or bone mass. Osteoporosis, Paget's disease, and osteogenesis imperfecta are some of the common bone diseases. Bone and mineral diagnostic tests are used for diagnosis and assessment of changes in response to bone diso …
- ナノメディシンの世界市場2015-2025Nanopharma – Discover Revenue Prospects Now, Benefiting Your Authority Do you want to find sales potentials of nanomedicine? If so, our new analysis gives you revenue forecasts to 2025 at overall world market, application, product and national level. That way you discover financial data, trends, R&D, opportunities and commercial outlooks. Visiongain’s study gives you revenue predictions from 2015 …
- Anything-as-a-Service（XaaS）の世界市場2016-2020About the Anything-as-a-Service (XaaS) Market XaaS is a cloud computing term that delivers a variety of services and applications to users via the Internet. XaaS also known as everything-as-a-service refers to the increasing number of services delivered through cloud over the Internet rather than providing locally or on-premises. The most common service types of XaaS are software-as-a-service (Saa …
- 世界の水集約産業用の化学薬品市場動向（2014～2018）TechNavio's analysts forecast the Global Chemicals for Water-intensive Industries market to grow at a CAGR of 3.28 percent over the period 2013-2018. One of the key factors contributing to this market growth is the increased demand from the Oil and Mining industry. The Global Chemicals for Water-intensive Industries market has also been witnessing the provision of supporting services by vendors. H …
- シリカゲルの世界市場2016-2020About Silica Gel Silica gel, a form of silicon dioxide, is prepared commercially by the acidification of sodium silicate. It is used in a variety of commercial, industrial, and household applications and is available in the market in various forms and product types. Technavio’s analysts forecast the global silica gel market to grow at a CAGR of 6.21% during the period 2016-2020. [Covered in this r …
- 食品着色料の世界市場：天然着色料、合成着色料About natural and synthetic food color Food colors are any type of dye, pigments, or substances that impart color when added to food or drinks. The exact color of the dye or pigment depends on the concentration, pH, and nature of the food. The food colors can be segmented as natural and synthetic food colors. Natural food colors are extracted from vegetables, fruit, minerals, and animals. They do …
- データセンター冷却装置の世界市場：エアコン、チラー、冷却塔、エコノマイザAbout data center cooling Cooling solutions are used in data centers to reduce the heat generated by the IT equipment. Many CRAC and CRAH units including air conditioners, chillers, cooling towers, economizers, humidifiers, and modern containment systems are used in data centers to furnish rack cooling. These cooling units use air, water, and liquid cooling systems for operation. The cooling proce …
